Robert Peters

Lysosomal Therapeutics (United States) — United States

Medicine · Health Sciences

24h-index3.3kcitations93works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemophilia Treatment and Research(41), Platelet Disorders and Treatments(19), Blood Coagulation and Thrombosis Mechanisms(19), Monoclonal and Polyclonal Antibodies Research(17), Protein purification and stability(8)

Publications93 total

1019 Discovery of lineage specific regulatory elements for development of in vivo CAR immune cell therapy via hematopoietic stem cell engineering
Regular and Young Investigator Award Abstracts·2025Open Access
Large hiatus hernia requiring hiatoplasty - An ongoing challenge: A case series
Journal of Pediatric Surgery·2025
Efficacy of Chest Drain and Fibrinolytic Therapy for Paediatric Empyema: A Single-Centre Retrospective Review
SVU-International Journal of Medical Sciences·2025Open Access
Identifying active and inhibitor-resistant MGMT variants for gene therapy
The American Journal of Human Genetics·2025Open Access
Single Dose of Tgroβ (EN-145)/Plerixafor Safely and Effectively Mobilizes Primitive HSCs in Mouse Models for In Vivo Gene Therapy of Sickle Cell Disease
Blood·2024Open Access
<i>In Vivo</i> Hematopoietic Stem Cell Engineering Restores the Function of NADPH Enzyme Complex in X-Linked Chronic Granulomatous Disease Model Mice
Blood·2024· 2 citedOpen Access
1098 In vivo VLP-based engineering generates multi-lineage CAR-immune cells that mediate potent and durable anti-tumor activity
Regular and Young Investigator Award Abstracts·2024· 1 citedOpen Access
Zinc finger nuclease-mediated gene editing in hematopoietic stem cells results in reactivation of fetal hemoglobin in sickle cell disease
Scientific Reports·2024· 11 citedOpen Access
Nano-org, a functional resource for single-molecule localisation microscopy data
2024Open Access
Biodistribution of recombinant factor IX, extended half-life recombinant factor IX Fc fusion protein, and glycoPEGylated recombinant factor IX in hemophilia B mice
Blood Coagulation & Fibrinolysis·2023· 7 citedOpen Access
Laparoscopic hernia repair in children: does recreating the open operation improve outcomes? A systematic review
Hernia·2023· 13 citedOpen Access
Genomic discovery and functional validation of MRP1 as a novel fetal hemoglobin modulator and potential therapeutic target in sickle cell disease
2023· 3 citedOpen Access
<i>Inhibition of MRP1 Induces Fetal Hemoglobin through NRF2 Activation to Protect Human Erythroid Cells from Sickling</i>
Blood·2022
Does Timing of Resection Influence the Presence of Inflammation within Congenital Lung Malformations?
European Journal of Pediatric Surgery·2022· 7 cited
The Management of Asymptomatic Congenital Pulmonary Airway Malformation: Results of a European Delphi Survey
Children·2022· 17 citedOpen Access
Efanesoctocog alfa elicits functional clot formation that is indistinguishable to that of recombinant factor VIII
Journal of Thrombosis and Haemostasis·2022· 18 citedOpen Access
Structural, functional, and immunogenicity implications of <i>F9</i> gene recoding
Blood Advances·2022· 13 citedOpen Access
Laparoscopic splenectomy: how minimal can we make it?
Journal of Pediatric Endoscopic Surgery·2022· 2 citedOpen Access
Congenital oesophageal stenosis in oesophageal atresia: underrecognised and often missed?
Pediatric Surgery International·2021· 4 cited
P150 UTILISATION OF OVINE REINFORCED TISSUE MATRIX IN PAEDIATRIC RECONSTRUCTIVE SURGERY
British journal of surgery·2021Open Access
page 1 of 5Next →

Frequent Co-authors

Jennifer Dumont(13), Glenn F. Pierce(12), Qi Lü(10), Joe Salas(9), Tongyao Liu(8), John D. Kulman(8), Haiyan Jiang(7), Alan J. Bitonti(7), Ekta Seth Chhabra(7), Susan C. Low(6), Volker Schellenberger(5), Baisong Mei(5), Nina C. Leksa(5), Nick Lansdale(5), David Wilkinson(5), Susannah Patarroyo‐White(4), Douglas Drager(4), Jürg M. Sommer(4), Arjan van der Flier(4), Tom Maniatis(3)